iopentol

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2012
0102019872012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
BACKGROUND The study was designed to investigate the influence of haemodialysis on the pharmacokinetics of the non-ionic contrast… (More)
Is this relevant?
1997
1997
The non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 350 mg I/ml was compared for safety and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
1994
1994
In pediatric radiology there is a great demand for a safe contrast medium. In this pediatric CT trial, the safety, tolerability… (More)
Is this relevant?
1992
1992
A double-blind comparative study of the nonionic contrast medium iopentol and the ionic contrast medium metrizoate for urography… (More)
Is this relevant?
1991
1991
Renal effects of the 2 non-ionic contrast media iopentol and iohexol were investigated and compared in a double-blind, randomized… (More)
Is this relevant?
1987
1987
Iopentol is a new non-ionic contrast medium. In order to study the pharmacokinetic properties, iopentol 350 mg I/ml was… (More)
Is this relevant?
1987
1987
Testing of the intravenous toxicity (LD50) of iopentol in mice and rats showed results comparable to the toxicity of non-ionic… (More)
Is this relevant?
1987
1987
The autoclaving studies which were performed to develop a formulation of iopentol are presented. The same formulation as used for… (More)
Is this relevant?
1987
1987
Repeat dose toxicity studies, reproductive studies and mutagenicity studies were performed to assess the safety of iopentol. It… (More)
Is this relevant?
1987
1987
Fifteen isolated rabbit hearts were perfused with Krebs' solution according to the Langendorff technique. Before, during, and… (More)
Is this relevant?